标题
ERRα mediates metabolic adaptations driving lapatinib resistance in breast cancer
作者
关键词
-
出版物
Nature Communications
Volume 7, Issue -, Pages 12156
出版商
Springer Nature
发表日期
2016-07-12
DOI
10.1038/ncomms12156
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A roadmap for interpreting 13 C metabolite labeling patterns from cells
- (2015) Joerg M Buescher et al. CURRENT OPINION IN BIOTECHNOLOGY
- Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family Bromodomains
- (2015) Timothy J. Stuhlmiller et al. Cell Reports
- ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics
- (2014) Carlos L. Arteaga et al. CANCER CELL
- PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis
- (2014) Valerie S. LeBleu et al. NATURE CELL BIOLOGY
- PGC1α Expression Defines a Subset of Human Melanoma Tumors with Increased Mitochondrial Capacity and Resistance to Oxidative Stress
- (2013) Francisca Vazquez et al. CANCER CELL
- Optical Metabolic Imaging Identifies Glycolytic Levels, Subtypes, and Early-Treatment Response in Breast Cancer
- (2013) A. J. Walsh et al. CANCER RESEARCH
- Molecular and Genetic Crosstalks between mTOR and ERRα Are Key Determinants of Rapamycin-Induced Nonalcoholic Fatty Liver
- (2013) Cédric Chaveroux et al. Cell Metabolism
- Signaling cross-talk in the resistance to HER family receptor targeted therapy
- (2013) H Yamaguchi et al. ONCOGENE
- Loss of estrogen-related receptor promotes hepatocarcinogenesis development via metabolic and inflammatory disturbances
- (2013) E.-J. Hong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pharmacologic Inhibition of mTOR Improves Lapatinib Sensitivity in HER2-Overexpressing Breast Cancer Cells with Primary Trastuzumab Resistance
- (2012) Sylvia S. Gayle et al. Anti-Cancer Agents in Medicinal Chemistry
- PI3K independent activation of mTORC1 as a target in lapatinib-resistant ERBB2+ breast cancer cells
- (2012) Anna-Maria Jegg et al. BREAST CANCER RESEARCH AND TREATMENT
- The Skp2-SCF E3 Ligase Regulates Akt Ubiquitination, Glycolysis, Herceptin Sensitivity, and Tumorigenesis
- (2012) Chia-Hsin Chan et al. CELL
- Mechanisms of acquired resistance to targeted cancer therapies
- (2012) Mark R Lackner et al. Future Oncology
- Regression of a meningioma during paclitaxel and bevacizumab therapy for breast cancer
- (2012) Thomas J. Wilson et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Antitumor Activity of a Novel Bispecific Antibody That Targets the ErbB2/ErbB3 Oncogenic Unit and Inhibits Heregulin-Induced Activation of ErbB3
- (2012) C. F. McDonagh et al. MOLECULAR CANCER THERAPEUTICS
- The glucose-deprivation network counteracts lapatinib-induced toxicity in resistant ErbB2-positive breast cancer cells
- (2012) Kakajan Komurov et al. Molecular Systems Biology
- Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors
- (2012) Timothy R. Wilson et al. NATURE
- The PGC-1/ERR signaling axis in cancer
- (2012) G Deblois et al. ONCOGENE
- Molecular signatures database (MSigDB) 3.0
- (2011) A. Liberzon et al. BIOINFORMATICS
- Neuregulin-1-Mediated Autocrine Signaling Underlies Sensitivity to HER2 Kinase Inhibitors in a Subset of Human Cancers
- (2011) Timothy R. Wilson et al. CANCER CELL
- The Metabolic Regulator ERRα, a Downstream Target of HER2/IGF-1R, as a Therapeutic Target in Breast Cancer
- (2011) Ching-yi Chang et al. CANCER CELL
- Identification of Diaryl Ether-Based Ligands for Estrogen-Related Receptor α as Potential Antidiabetic Agents
- (2011) Raymond J. Patch et al. JOURNAL OF MEDICINAL CHEMISTRY
- Combinatorial Effects of Lapatinib and Rapamycin in Triple-Negative Breast Cancer Cells
- (2011) T. Liu et al. MOLECULAR CANCER THERAPEUTICS
- Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
- (2011) Richard Possemato et al. NATURE
- The PI3 kinase/mTOR blocker NVP-BEZ235 overrides resistance against irreversible ErbB inhibitors in breast cancer cells
- (2010) Caroline Brünner-Kubath et al. BREAST CANCER RESEARCH AND TREATMENT
- Transcriptional Control of the ERBB2 Amplicon by ERR and PGC-1 Promotes Mammary Gland Tumorigenesis
- (2010) G. Deblois et al. CANCER RESEARCH
- Clinical Benefit of Lapatinib-Based Therapy in Patients with Human Epidermal Growth Factor Receptor 2-Positive Breast Tumors Coexpressing the Truncated p95HER2 Receptor
- (2010) M. Scaltriti et al. CLINICAL CANCER RESEARCH
- The homeobox protein Prox1 is a negative modulator of ERR /PGC-1 bioenergetic functions
- (2010) A. Charest-Marcotte et al. GENES & DEVELOPMENT
- Fast and accurate short read alignment with Burrows-Wheeler transform
- (2009) H. Li et al. BIOINFORMATICS
- 1-Integrin Circumvents the Antiproliferative Effects of Trastuzumab in Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer
- (2009) D. Lesniak et al. CANCER RESEARCH
- PTEN Deficiency in a Luminal ErbB-2 Mouse Model Results in Dramatic Acceleration of Mammary Tumorigenesis and Metastasis
- (2009) Babette Schade et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Phosphatidylinositol 3-Kinase Hyperactivation Results in Lapatinib Resistance that Is Reversed by the mTOR/Phosphatidylinositol 3-Kinase Inhibitor NVP-BEZ235
- (2008) P. J.A. Eichhorn et al. CANCER RESEARCH
- Autocrine Production of Amphiregulin Predicts Sensitivity to Both Gefitinib and Cetuximab in EGFR Wild-type Cancers
- (2008) K. Yonesaka et al. CLINICAL CANCER RESEARCH
- Acquired resistance to tyrosine kinase inhibitors during cancer therapy
- (2008) Jeffrey A Engelman et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- ShcA signalling is essential for tumour progression in mouse models of human breast cancer
- (2008) Josie Ursini-Siegel et al. EMBO JOURNAL
- Transcriptional Control of Energy Homeostasis by the Estrogen-Related Receptors
- (2008) Vincent Giguère ENDOCRINE REVIEWS
- The tyrosine kinase receptor HER2 (erbB-2): From oncogenesis to adipogenesis
- (2008) Alejandro Vazquez-Martin et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Model-based Analysis of ChIP-Seq (MACS)
- (2008) Yong Zhang et al. GENOME BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now